PAS
IDXX icon

Park Avenue Securities’s Idexx Laboratories IDXX Stock Holding History

Park Avenue Securities’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.22M Sell
2,321
-226
-9% -$127K 0.01% 859
2026
Q1 		$1.43M Sell
2,547
-35
-1% -$22.4K 0.01% 671
2025
Q4 		$1.75M Buy
2,582
+314
+14% +$214K 0.01% 593
2025
Q3 		$1.45M Sell
2,268
-202
-8% -$123K 0.01% 724
2025
Q2 		$1.32M Buy
2,470
+206
+9% +$98.5K 0.01% 671
2025
Q1 		$951K Buy
2,264
+351
+18% +$152K 0.01% 640
2024
Q4 		$791K Sell
1,913
-1,184
-38% -$519K 0.01% 866
2024
Q3 		$1.56M Sell
3,097
-510
-14% -$248K 0.02% 500
2024
Q2 		$1.76M Sell
3,607
-43
-1% -$21.6K 0.02% 454
2024
Q1 		$1.97M Sell
3,650
-245
-6% -$134K 0.03% 417
2023
Q4 		$2.16M Sell
3,895
-288
-7% -$135K 0.03% 360
2023
Q3 		$1.83M Buy
+4,183
New +$2.09M 0.03% 358
2023
Q1 		– Sell
-4,304
Closed -$1.76M – 913
2022
Q4 		$1.76M Sell
4,304
-199
-4% -$77.2K 0.03% 340
2022
Q3 		$1.47M Buy
4,503
+389
+9% +$143K 0.03% 339
2022
Q2 		$1.44M Buy
4,114
+472
+13% +$192K 0.03% 345
2022
Q1 		$1.99M Buy
3,642
+384
+12% +$202K 0.04% 282
2021
Q4 		$2.15M Buy
3,258
+133
+4% +$83.5K 0.04% 269
2021
Q3 		$1.94M Sell
3,125
-43
-1% -$28.9K 0.04% 246
2021
Q2 		$2M Sell
3,168
-287
-8% -$158K 0.04% 228
2021
Q1 		$1.69M Buy
3,455
+5
+0.1% +$2.5K 0.04% 229
2020
Q4 		$1.73M Buy
3,450
+733
+27% +$328K 0.05% 180
2020
Q3 		$1.07M Buy
2,717
+858
+46% +$317K 0.04% 229
2020
Q2 		$614K Buy
+1,859
New +$538K 0.02% 302

Other funds holding IDXX

MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
CGI
Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return
MJRIC
Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Park Avenue Securities's IDXX Position: Q2 2026 in Review

Park Avenue Securities reduced its Idexx Laboratories (IDXX) stake by 8.9% in Q2 2026, selling an estimated $127K and leaving 2,321 shares worth $1.22M. The position accounts for 0.01% of the portfolio, ranked #859.

Park Avenue Securities first reported a position in IDXX in Q2 2020 and has held it in 23 quarters since. The position peaked at $2.16M in Q4 2023. 330 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Park Avenue Securities held 2,321 shares of Idexx Laboratories worth $1.22M as of Q2 2026.
  • Park Avenue Securities sold 226 Idexx Laboratories shares in Q2 2026, an estimated $127K.
  • Idexx Laboratories made up 0.01% of Park Avenue Securities's portfolio in Q2 2026, its #859 holding.
  • Park Avenue Securities first reported a position in Idexx Laboratories in Q2 2020 and has held it in 23 quarters since.
  • Park Avenue Securities's Idexx Laboratories position peaked at $2.16M in Q4 2023.
  • 330 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.